Research ties insulin to higher mortality risk in diabetes

01/14/2013 | FoodConsumer.org

Type 2 diabetes patients who were on insulin treatment had an 89% higher risk of all-cause mortality and 116% higher risk of cancer-related death than nonusers, a study revealed. However, researchers noted diabetes patients on insulin did not have a higher overall risk of cancer. The findings appear in PLoS One.

View Full Article in:

FoodConsumer.org

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL